This Article Full Text Full Text (PDF) Submit a related Letter to the Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Riepe, F. G. Articles by Krone, N. Search for Related Content PubMed PubMed Citation Articles by Riepe, F. G. Articles by Krone, N. Related Collections Adrenal and Hypertension Pediatric Endocrinology

Elucidating the Underlying Molecular Pathogenesis of NR3C2 Mutants Causing Autosomal Dominant Pseudohypoaldosteronism Type 1

Division of Pediatric Endocrinology (F.G.R., J.F., W.G.S., N.K.), Department of Pediatrics, and Department of Pediatric Cardiology (M.V.), University Hospital Schleswig-Holstein, Campus Kiel, 24105 Kiel, Germany; Department of Pediatrics (L.d.S., A.T.), University of Torino, 10126 Torino, Italy; Division of Pediatric Endocrinology (S.E.), Regina Margherita Children’s Hospital, 10100 Torino, Italy; Pediatric Endocrinology (B.K.), University Children’s Hospital, University of Ulm, 89075 Ulm, Germany; Screening Laboratory Hannover (M.P.), 30952 Ronnenberg-Benthe, Germany; Institute of Biochemistry (J.G.), Christian-Albrechts-Universität zu Kiel, 24098 Kiel, Germany; and Department of Physiology (G.F.-T.), Dartmouth Medical School, Lebanon, New Hampshire 03756

Address all correspondence and requests for reprints to: Felix G. Riepe, M.D., Division of Pediatric Endocrinology, Department of Pediatrics, University Hospital Schleswig-Holstein, Schwanenweg 20, D-24105 Kiel, Germany. E-mail: friepe{at}pediatrics.uni-kiel.de.

Context: Pseudohypoaldosteronism type 1 (PHA1) is a rare salt-wasting syndrome. Mutations in the NR3C2 gene coding for the mineralocorticoid receptor (MR) cause autosomal dominant PHA1.

Objective: Our objective was to reveal the cause of renal salt loss in six PHA1 patients and analyze the mutants’ functional impact on MR function.

Design: Our study included the following: clinical and hormonal characterization of the patients’ phenotype, analysis of the NR3C2 gene, determination of receptor affinities to aldosterone and the transcriptional activation abilities of the MR mutants, investigation of subcellular translocation using fluorescence-labeled MR, and studying changes in mutant receptor conformation with proteolysis experiments and three-dimensional modeling.

Results: Six heterozygous NR3C2 mutations were detected. One frameshift mutation (c.1131dupT) has been reported previously. The second frameshift mutation (c.2871dupC), which has only recently been reported by our group, showed no aldosterone binding and no transactivation because of a major change in receptor conformation. Two novel nonsense mutations generate a truncated receptor protein. Two missense mutations differently affect MR function. S818L was reported recently without complete in vitro data. S818L does not bind aldosterone or activate transcription or translocate into the nucleus. A major displacement of several residues involved in aldosterone binding was PHA1 causing. The novel E972G mutation showed a significantly lower ligand-binding affinity and only 9% of wild-type transcriptional activity caused by major changes in receptor conformation.

Conclusions: Our data on six mutations extend the spectrum of PHA1-causing NR3C2 gene mutations. Studying naturally occurring mutants helps to clarify their pathogenicity and to identify crucial residues for MR structure and function.

This article has been cited by other articles:

				M. D. Tobin, M. Tomaszewski, P. S. Braund, C. Hajat, S. M. Raleigh, T. M. Palmer, M. Caulfield, P. R. Burton, and N. J. Samani Common Variants in Genes Underlying Monogenic Hypertension and Hypotension and Blood Pressure in the General Population Hypertension, June 1, 2008; 51(6): 1658 - 1664. [Abstract] [Full Text] [PDF]